Choong-Chin Liew

USPTO Granted Patents = 25 (Patent Applications = 24)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 1.6

ph-index = 13

Forward Citations = 592(Granted Patents)

Company Filing History:

Stagezero Life Sciences Ltd.

patent

Years Active: 2008-2021

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11053551 - Method and apparatus for determining a probability of colorectal cancer in a subject (2021-07-06),

2. 8921074 - Method and apparatus for determining a probability of colorectal cancer in a subject (2014-12-30),

3. 8669058 - Method of profiling gene expression in a subject having colorectal cancer (2014-03-11),

4. 8483968 - Method of diagnosing mild osteoarthritis (2013-07-09),

5. 8258284 - Kits and primers for diagnosing schizophrenia (2012-09-04),

6. 8257922 - Method of profiling gene expression in a subject having alzheimer's disease (2012-09-04),

7. 8249814 - Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject (2012-08-21),

8. 8239136 - Method, computer system and computer-readable medium for determining a probability of colorectal cancer in a test subject (2012-08-07),

9. 8148072 - Method of profiling gene expression in a subject having heart failure (2012-04-03),

10. 8142998 - Osteoarthritis biomarkers and uses thereof (2012-03-27),

11. 8133675 - Method of profiling gene expression in a subject having an infectious disease (2012-03-13),

12. 8133674 - Method of profiling gene expression in a subject having diabetes (2012-03-13),

13. 8114597 - Method of profiling gene expression in a subject undergoing a treatment (2012-02-14),

14. 8110358 - Method of profiling gene expression in a subject having prostate cancer (2012-02-07),

15. 8101358 - Method of profiling gene expression in a subject having disease (2012-01-24),

Title: **Choong-Chin Liew: Innovator in Cancer Detection**

Introduction

Choong-Chin Liew is a prominent inventor based in Toronto, Canada, with an impressive portfolio of 25 patents. His work primarily focuses on advancements in medical technology, particularly in the field of cancer detection. Liew's innovative methods have the potential to significantly enhance early diagnosis and treatment strategies for colorectal cancer.

Latest Patents

One of Liew's latest patents is a method and apparatus for determining a probability of colorectal cancer in a subject. This cutting-edge methodology involves analyzing gene expression levels in the blood of a test subject. By comparing these levels with positive and negative control data from human subjects with and without colorectal cancer, the method calculates the likelihood that the test subject has the disease. This innovation aims to provide more accurate cancer screenings and could play a pivotal role in the early detection of colorectal cancer.

Career Highlights

Throughout his career, Choong-Chin Liew has made significant contributions to the field of biomedical engineering. He has held positions at notable companies, including Genenews Corporation and Chondrogene Limited. His experience in these organizations has allowed him to collaborate with other experts in the field, promoting the development of pioneering health solutions.

Collaborations

Liew has worked alongside esteemed professionals such as Samuel Chao and Thomas Yager. Their collaborations have been instrumental in driving innovations that bridge the gap between genetic research and clinical applications, particularly in cancer diagnostics.

Conclusion

With a solid foundation in research and development, Choong-Chin Liew continues to push the boundaries of medical technology. His patents not only reflect his dedication to advancing cancer detection methods but also highlight the potential impact of his work on global health outcomes. As the field of cancer research evolves, inventors like Liew will remain at the forefront, shaping the future of medical diagnostics with their innovative solutions.

This text is generated by artificial intelligence and may not be accurate.